News
IMV to Showcase its DPX® Delivery Technology in Two Presentations at the AACR Annual Meeting 2022
IMV Inc. (Nasdaq: IMV; TSX: IMV), a clinical-stage company developing a portfolio of immune-educating therapies based on its novel DPX platform to treat solid and hematologic cancers, today
Biomind Labs Receives Approval for a Second Phase II Clinical Trial for Treatment-resistant Depression
Biomind Labs Inc. (“Biomind Labs” or the “Company”) (NEO: BMND) (OTC: CRSWF) (FSE: 3XI), a leading biotech company focused on innovation and research on endogenous tryptamines (biomolecules acting
Form 8.3 - The Vanguard Group, Inc.: NortonLifeLock Inc.
Pfizer Initiates Phase 2/3 Study of Novel COVID-19 Oral Treatment in Pediatric Participants
Pfizer Inc. (NYSE: PFE) announced today that it has initiated a Phase 2/3 study, EPIC-PEDS (Evaluation of Protease Inhibition for COVID-19 in Pediatric Patients), to evaluate the safety
DGAP-Adhoc: GRAMMER Aktiengesellschaft: Supervisory Board members Alfred Weber and Dr. Peter Merten resign their mandats at the end of the Annual General Meeting
DGAP-News: Deutsche Post AG: Announcement pursuant to Art. 5 para 1 of Regulation (EU) No. 596/2014 in conjunction with Art. 2 para 1 of the Delegated Regulation (EU) 2016/1052 of the Commission
Lenovo Delivers Future-Ready IT Infrastructure for Midsize Companies
Today, Lenovo (HKSE: 992) (ADR: LNVGY) introduced newly customized IT infrastructure solutions for midsize businesses, with a complete series of easy-to-use solutions and services to help them
NICE CXone Gets Top Honors for Contact Center Platforms in Metrigy Research
NICE (Nasdaq: NICE) today announced that it has been recognized as a MetriStar Top Provider in the Contact Center Platform category from among 16 companies evaluated. Based on a ranking of
Transgene to Present New Positive Preliminary Phase I Data on TG4050 (myvac® platform), its Individualized Therapeutic Cancer Vaccine, at AACR 2022
Regulatory News:
Transgene (Euronext Paris: TNG) (Paris:TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer will be presenting a poster with
Transgene and BioInvent Announce Poster Presentation on BT-001, a Novel Antibody-encoding Oncolytic Virus, at AACR 2022
Regulatory News:
Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapeutics against cancer, and BioInvent International AB (“BioInvent”) (Nasdaq
DGAP-News: Continental Generates Profit and Expects Further Improvement in Results
DGAP-News: Nordex Group: preliminary annual figures for 2021 confirm guidance
Very successful financial year 2021
AEVIS VICTORIA SA (AEVS:SW) announces 2021 revenues of CHF 895.9 million, up by 22.2%
DGAP-News: Klöckner & Co SE delivers best operating income in fiscal year 2021 since IPO
DGAP-News: Siltronic AG closes fiscal 2021 with strong earnings - dividend of EUR 3.00 per share proposed
United Bank Announces New President
Richard M. Adams, Chairman of the Board of United Bank (“United”), announced the Board’s approval of the promotion of Julie R. Gurtis to President effective April 1, 2022.
Julie Gurtis currently
Schlumberger Launches Dedicated Business to Eliminate Oil and Gas Industry’s Methane and Routine Flare Emissions
Schlumberger announced today the launch of Schlumberger End-to-end Emissions Solutions (SEES). The business offers a comprehensive set of services and cutting-edge technologies designed to give
Granite Removes Large Boulder Blocking Popular Route to Lake Tahoe
Granite’s (NYSE:GVA) Nevada Region responded to a roadway emergency on US Highway 50 near Echo Summit where a gigantic boulder slid, blocking traffic in and out of the Lake Tahoe Basin. The
Columbus McKinnon to Webcast Presentation at 2022 JP Morgan Industrials Conference
Columbus McKinnon Corporation (Nasdaq: CMCO), a leading designer and manufacturer of intelligent motion solutions for material handling, today announced that David Wilson, President and Chief
Exscientia to Highlight Precision Medicine Platform and Pipeline Data at the American Association of Cancer Research Annual Meeting 2022
Exscientia (Nasdaq: EXAI) today announced the acceptance of three abstracts for poster presentation at the upcoming American Association for Cancer Research (AACR) Annual Meeting 2022, being held
Investors Title Company Declares Quarterly Dividend
Investors Title Company (Nasdaq: ITIC) announced today that the Company's Board of Directors has declared a cash dividend of $.46 per share to shareholders of record March 21, 2022, payable March
Xencor to Present Preclinical Data from XmAb® Cytokine Programs at the American Association for Cancer Research (AACR) Annual Meeting 2022
Xencor, Inc. (NASDAQ: XNCR), a clinical-stage biopharmaceutical company developing engineered antibodies and cytokines for the treatment of cancer and autoimmune diseases, today announced it will
Civitas Resources Announces Fourth Quarter and Full-Year 2021 Results; Declares Dividend to be Paid in March
Civitas Resources, Inc. (NYSE: CIVI) (the "Company" or "Civitas") today announced its fourth quarter and full-year 2021 financial results, and has posted an updated investor presentation to its
Fuel Tech Reports 2021 Fourth Quarter and Full Year Financial Results
Fuel Tech, Inc. (NASDAQ: FTEK), a technology company providing advanced engineering solutions for the optimization of combustion systems, emissions control, and water treatment in utility and